ES2060392T3 - Nueva region promotora. - Google Patents

Nueva region promotora.

Info

Publication number
ES2060392T3
ES2060392T3 ES91911248T ES91911248T ES2060392T3 ES 2060392 T3 ES2060392 T3 ES 2060392T3 ES 91911248 T ES91911248 T ES 91911248T ES 91911248 T ES91911248 T ES 91911248T ES 2060392 T3 ES2060392 T3 ES 2060392T3
Authority
ES
Spain
Prior art keywords
promoting region
new
new promoting
region
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911248T
Other languages
English (en)
Inventor
Roland Kurth
Peter Philippsen
Sabine Steiner
Martin C Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2060392T3 publication Critical patent/ES2060392T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P25/00—Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

SE DESCRIBE LA REGION DE PROMOTOR DEL GEN A. GOSSYPII, LA CUAL CODIFICA EL FACTOR DE ELONGACION DE TRASLACION EF-1 ALFA. EL PROMOTOR PUEDE SER UTILIZADO EN LA SINTESIS DE PROTEINAS.
ES91911248T 1990-06-25 1991-06-15 Nueva region promotora. Expired - Lifetime ES2060392T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4020181A DE4020181A1 (de) 1990-06-25 1990-06-25 Neue promotorregion

Publications (1)

Publication Number Publication Date
ES2060392T3 true ES2060392T3 (es) 1994-11-16

Family

ID=6409025

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911248T Expired - Lifetime ES2060392T3 (es) 1990-06-25 1991-06-15 Nueva region promotora.

Country Status (8)

Country Link
EP (1) EP0536192B1 (es)
JP (1) JP3059214B2 (es)
AT (1) ATE110779T1 (es)
CA (1) CA2080482C (es)
DE (2) DE4020181A1 (es)
DK (1) DK0536192T3 (es)
ES (1) ES2060392T3 (es)
WO (1) WO1992000379A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989870A (en) * 1986-04-30 1999-11-23 Rohm Enzyme Finland Oy Method for cloning active promoters
WO1993004180A1 (de) * 1991-08-22 1993-03-04 Basf Aktiengesellschaft Verfahren zur gezielten genetischen veränderung von ashbya gossypii
DK0569806T3 (da) * 1992-05-11 2001-12-31 Basf Ag DNA-forbindelser og rekombinante DNA-ekspressionsvektorer, der koder for riboflavinsyntetaseaktivitet af S. cerevisiae
DE19521314A1 (de) * 1995-06-12 1996-12-19 Max Planck Gesellschaft Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid
EP0927761A3 (de) 1997-12-23 2001-09-05 Basf Aktiengesellschaft Gene der Purinbiosyntese aus Ashbya gossypii und deren Verwendung in der mikrobiellen Riboflavinsynthese
DE19801120A1 (de) 1998-01-15 1999-07-22 Basf Ag Orotidin-5'-Phosphatdecarboxylase-Gen, Genkonstrukt enthaltend dieses Gen und seine Verwendung
US7673432B2 (en) * 2004-03-11 2010-03-09 The Hong Kong Polytechnic University Double-skin tubular structural members
CN108251476B (zh) * 2018-02-01 2021-09-07 湖南鸿鹰生物科技有限公司 从酶制剂废水中提取维生素b12的方法

Also Published As

Publication number Publication date
ATE110779T1 (de) 1994-09-15
JPH06500007A (ja) 1994-01-06
CA2080482A1 (en) 1991-12-26
EP0536192A1 (de) 1993-04-14
EP0536192B1 (de) 1994-08-31
DE4020181A1 (de) 1992-01-02
JP3059214B2 (ja) 2000-07-04
CA2080482C (en) 2002-10-01
DE59102761D1 (de) 1994-10-06
DK0536192T3 (da) 1994-10-03
WO1992000379A1 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
DE69023948D1 (de) Herstellung von peroxidhaltigen Perfluorpolyethern.
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
EP0337713A3 (en) 2-substituted-4-substituted-1,3-dioxolanes, synthesis and use thereof
DK0503035T3 (da) Hidtil ukendt 1alfa-hydroxy-vitamin D4 og hidtil ukendte mellemprodukter og analoger
DE69018071D1 (de) Herstellung von peroxysäuren.
DE69103444D1 (de) Herstellung von Glasgegenständen.
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE68908046D1 (de) Instrument fuer inokulation von zwiebelschalen.
IT1218140B (it) Regolatore di vuoto
ES2060392T3 (es) Nueva region promotora.
DE69213447D1 (de) Herstellung von n-acylimidazolen
DE69015460D1 (de) Ineinandergeschachtelte Anordnung von Hornstrahlern.
DE68917099D1 (de) Produktion von sekundären aliphatischen Aminen.
DE68921340D1 (de) Herstellung von epoxinitraten.
DE68912278D1 (de) Verformung von verbundenen abrasiven Produkten.
DE69033814D1 (de) Herstellung von alpha-ungesättigten Aminen
DE3769352D1 (de) Mischungen von optischen aufhellern.
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DE69002496D1 (de) Herstellung von fluorphenolen.
DE3751594D1 (de) Mischungen von optischen Aufhellern.
FI881111A0 (fi) Foerfarande foer framstaellning av polyklorfosfazen.
DE69003306D1 (de) Reinigung von Proteinhydrolysaten.
DE59004528D1 (de) Verwendung des (+)-enantiomeren von anipamil.
IT1226796B (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IT1231255B (it) Peptidi anoressizzanti e ipotensivi.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 536192

Country of ref document: ES